MHLW Warns Of Side Effects For 13 Drugs
This article was originally published in PharmAsia News
Executive Summary
Japan MHLW’s Pharmaceutical and Food Safety Bureau issued a notification to the Federation of Pharmaceutical Manufacturers Association regarding 13 components in drugs that require revisions to package inserts to advise patients of possible side effects.
Japan MHLW’s Pharmaceutical and Food Safety Bureau on Nov. 26 issued a notification to the Federation of Pharmaceutical Manufacturers Association regarding 13 components in drugs that require revisions to package inserts to advise patients of possible side effects. According to the ministry, these drugs can cause dizziness, and patients must be warned of this particularly when driving or operating similar machines. The components on the warning list are: donepezil, pilsicainide, propafenone, bepridil, beraprost, azithromycin, ofloxacin, garenoxacin, levofloxacin, telaprevir, famciclovir, acyclovir, and valacyclovir. (Click Here For More – Japanese Language
)
“MHLW Cautions About Driving After Administration, Warns Of Vertigo Etc. Regarding 13 Drugs” - mixonline.jp 11/28/2013